Jci_page_head_homepage_01 Jci_page_head_homepage_02
Yvonne G. Weber, Alexander Storch, Thomas V. Wuttke, Knut Brockmann, Judith Kempfle, Snezana Maljevic, Lucia Margari, Christoph Kamm, Susanne A. Schneider, Stephan M. Huber, Arnulf Pekrun, Robert Roebling, Guiscard Seebohm, Saisudha Koka, Camelia Lang, Eduard Kraft, Dragica Blazevic, Alberto Salvo-Vargas, Michael Fauler, Felix M. Mottaghy, Alexander Münchau, Mark J. Edwards, Anna Presicci, Francesco Margari, Thomas Gasser, Florian Lang, Kailash P. Bhatia, Frank Lehmann-Horn, Holger Lerche
Published in Volume 118, Issue 6
J Clin Invest. 2008; 118(6):2157–2168 doi:10.1172/JCI34438
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 2
Genetic investigations.

(A) Genomic sequences of a normal control (upper panel), the index patient (middle panel), and the cloned, mutant allele from the index patient (lower panel), revealing a 12-bp deletion at nucleotide 1,022 and loss of amino acids 282–285 (QQLS). The black line below the upper panel denotes the exact deleted region of the 12 bp. (B) Proposed structure of GLUT1 with 12 transmembrane segments (T1–12) and the location of Q282_S285del (red). A central pore (hatched region in the extracellular view) may be formed by segments marked in gray or red. (C) The deleted motif QQLS is highly conserved among species and other glucose transporters.